Camille Kropp

The Keystone commensal bacterium Christensenella minuta DSM 22607 displays anti-inflammatory properties both in vitro and in vivo

P. Langella, Sandrine P. Claus, Rebeca Martín, 2021, Scientific Reports.

Selection of a novel strain of Christensenella minuta as a future biotherapy for Crohn’s disease

Sandrine P. Claus, Guillaume Déjean, G. Rawadi, 2022, Scientific reports.

Intraspecific Diversity of Microbial Anti-Inflammatory Molecule (MAM) from Faecalibacterium prausnitzii

V. Azevedo, J. Chatel, P. Langella, 2022, International journal of molecular sciences.

Rapeseed oil fortified with micronutrients improves cognitive alterations associated with metabolic syndrome

N. Castanon, J. Chardigny, S. Layé, 2019, Brain, Behavior, and Immunity.

A New Strain of Christensenella minuta as a Potential Biotherapy for Obesity and Associated Metabolic Diseases

Sandrine P. Claus, G. Rawadi, W. Mazier, 2021, Cells.

From In Vitro to In Vivo: A Rational Flowchart for the Selection and Characterization of Candidate Probiotic Strains in Intestinal Disorders

H. Sokol, S. Mondot, P. Langella, 2023, Microorganisms.